Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease

Documenti analoghi

• Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study
  Pubblicazione: (2013)
• The underestimated impact of smoking and smoking cessation on the risk of secondary cardiovascular disease events in patients with stable coronary heart disease: prospective cohort study
  Pubblicazione: (2006)
• Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events
  Pubblicazione: (2005)
• Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease
  Pubblicazione: (2011)
• Cytochrome P450 2C19*2 polymorphism in patients with stable coronary heart disease and risk for secondary cardiovascular disease events: results of a long-term follow-up study in routine clinical care
  di: Rothenbacher, Dietrich, et al.
  Pubblicazione: (2013)